Durham, North Carolina — According to state and local economic development sources Beam Therapeutics plans to invest $83,000,000.00 to build out new space in Durham. The company plans to occupy the new space in Durham, on or about January 1, 2022. According to the company website Our vision is to provide life-long cures to patients suffering from serious diseases. Beam is pioneering the use of base editing a potential new class of precision genetic medicines with a vision of providing life-long cures to patients suffering from serious diseases. Base editors enable us to precisely and permanently rewrite a single letter of the genome and potentially create life-long cures for patients suffering from serious diseases.

To learn more about Beam Therapeutics, visit http://beamtx.com/

Company Contact:
John Evans, Chief Executive Officer
https://www.linkedin.com/in/john-evans-2b7aa213/
857-327-8775

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved